What are the key investigational studies to keep an eye on in higher-risk MDS patients in the post-AZA setting?
FAQ Library published on December 9, 2020
In this activity, Dr. Rami Komrokji explains which investigational studies to review in the post-AZA setting.
As a community practitioner, what key factors do I need to remember in determining treatment options for my patients?
FAQ Library published on November 30, 2020
In this activity, Dr. Rami Komrokji discusses the recent progress made in anemia management and lower-risk MDS.
What is the clinical significance of SF3B1 in MDS and what are the key points I need to be aware of to determine treatment and outcome of these patients?
FAQ Library published on November 25, 2020
In this activity, Dr. Rami Komrokji describes the best way to determine treatment for patients with SF3B1 mutation.
Results 1 - 3 of 3